A provocative new concept from Kazan has emerged: an immortality capsule that combines artificial intelligence with a virtual reality headset to scan the body. The claim comes from Timur Serazetdinov, who holds the patent, and has been reported by kp.ru. The project has drawn attention because it suggests a bold use of technology to monitor and understand human health in a way that goes beyond conventional checkups, aiming to provide ongoing insight rather than a one-time snapshot.
According to the developers, a select group of Tatarstan doctors and researchers contributed to the hardware framework. The device is described as capable of examining major organs such as the heart, liver, and kidneys while also tracking vital signs like blood pressure, pulse, oxygen saturation, and glucose levels. Beyond that, it is said to evaluate the condition of blood vessels and the nervous system, with the overarching goal of extending lifespans through modern diagnostic methods. The messaging frames the capsule as a bridge between rapid screening and targeted, patient-specific follow-up care.
Serazetdinov explains that the capsule operates on a Holter-style principle: a continuous health check that can unfold over several days. The system reportedly requires roughly two minutes of AI processing per day to assemble a preliminary assessment and guide the user toward appropriate medical specialists. He cautions that the capsule cannot provide a definitive diagnosis for conditions like cirrhosis, but it can identify indicators such as skin changes or yellowing of the eyes and skin, which may prompt the user to seek professional evaluation. This staged approach is intended to empower early medical engagement and complement physician expertise rather than replace it. (kp.ru)
The inventor also suggested that the capsule might tailor travel recommendations based on an individual health survey, though specifics regarding safety, privacy, and long-term reliability were not exhaustively detailed. He asserts that the device has no global equal at present and places a preliminary price around 12 million rubles. The figures are framed as early estimates, with the emphasis on data-driven insights guiding human doctors rather than autonomous care decisions. (kp.ru)
At the time of discussion, three pre-orders were reportedly in place, yet the team indicated that retail availability would follow only after a clearer assessment of market demand. The objective is to validate the concept in real-world use before broad production and distribution unfold. The plan centers patient safety and clinical relevance within the development strategy, while actively seeking feedback from healthcare professionals and prospective buyers. (kp.ru)
Separately, a day earlier, researchers at the National University of Singapore highlighted a trend among younger people showing a higher risk of certain gastrointestinal cancers. This context, reported by Public News Service, is presented as part of ongoing efforts to improve early detection and preventive strategies across diverse populations. (Public News Service)
In a related development, scientists at a leading Siberian medical institute, NMIC named after EN Meshalkin, announced progress toward preserving donor hearts for longer periods. The approach involves keeping the heart functioning outside the body with a controlled supply of blood and oxygen, potentially extending viability time by about one and a half times. While the topic is technical and specialized, it underscores the broader push to improve outcomes in heart transplantation and critical care. (NMIC Meshalkin)
The report closes with reflections on ongoing debates about the balance of innovation, affordability, and patient impact. As medical technology grows more sophisticated, experts stress careful evaluation of benefits, risks, and real-world practicality. Public discourse continues to explore how new tools might complement traditional medical practice, improve early detection, and support healthier aging outcomes. (various reports)